Hypothesis: Neonatal respiratory distress may be related to asymptomatic colonization with group B streptococci

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 884-888

  Lin, Feng Ying C ^a   Troendle, James F ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Colonization; Group B streptococci; Intrapartum penicillin; Respiratory distress

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BLOOD CULTURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; LABOR; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; ONSET AGE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STREPTOCOCCUS AGALACTIAE;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; OXYGEN INHALATION THERAPY; PENICILLINS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33749451595     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000239322.58890.94     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Early-onset group B streptococcal disease - United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 2000;49:793-796.
2. Baker CJ. Group B streptococcal infections. Adv Intern Med. 1980;25:475-501.
3. McCracken GH. Group B streptococci: The new challenge in neonatal infections. J Pediatr. 1973;83:703-706.
4. Katzenstein A, Davis C, Braude A. Pulmonary changes in neonatal sepsis due to group B β-hemolytic streptococcus: Relation to hyaline membrane disease. J Infect Dis. 1976;133:430-435.
5. Weisman LE, Stall BJ, Cruess DF, et al. Early-onset group B streptococcal sepsis: A current assessment. J Pediatr. 1992;121:428-433.
6. Payne NR, Burke BA, Day DL, Christenson PD, Thompson TR, Ferrieri P. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J. 1988;7:836-847.
7. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115:1240-1246.
8. Rojas J, Stahlman M. The effects of group B streptococcus and other organisms on the pulmonary vasculature. Clin Perinatol. 1984;11:591-599.
9. Gibson RL, Truog WE, Redding GJ. Thromboxane-associated pulmonary hypertension during three types of Gram-positive bacteremia in piglets. Pediatr Res. 1989;23:553-556.
10. Philips JB III, Lyrene RK, Godoy G, et al. Hemodynamic responses of chronically instrumented piglets to bolus injections of group B streptococci. Pediatr Res. 1988;23:81-85.
11. Rundle B, Goldbery RN, Streitfeld MM, et al. Cardiovascular changes in group B streptococcal sepsis in the piglet: Response to indomethacin and relationship to prostacyclin and thromboxane A2. Pediatr Res. 1984;18:874-878.
12. Tarpey MN, Graybar GB, Lyrene RK, et al. Thromboxane synthesis inhibition reverses group B streptococcus-induced pulmonary hypertension. Crit Care Med. 1987;15:644-647.
13. Curtis J, Kim G, Wehr NB, Levine RL. Group B streptococcal phospholipid causes pulmonary hypertension. PNAS. 2003;100:5087-5090.
14. Cabacungan E, Pieringer RA. Excretion of extracellular lipids by Streptococcus mutans BHT and FA-1. Infect Immun. 1980;27:556-562.
15. Horne D, Hakenbeck R, Tomasz A. Secretion of lipids induced by inhibition of peptidoglycan synthesis in streptococci. J Bacteriol. 1977;132:704-717.
16. Brissette JL, Shockman GD, Pieringer RA. Effects of penicillin on synthesis and excretion of lipid and lipoteichoic acid from Streptococcus mutans BHT. J Bacteriol. 1982;151:838-844.
17. Brissette JL, Pieringer RA. The effect of penicillin on fatty acid synthesis and excretion in Streptococcus mutans. Lipids. 1985;20:173-179.
18. Lin FY, Philips JB III, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by type 1a group B streptococcus: A multi-center, seroepidemiology study. J Infect Dis. 2001;184:1022-1028.
19. Lin FY, Weisman LE, Azimi PH, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis. 2004;190:928-934.
20. Skov T, Deddens J, Pelersen MR, Endahl L. Prevalence proportion ratios: Estimation and hypothesis testing. Int J Epidemiol. 1998;27:91-95.
21. SAS/STAT Software: Changes and Enhancement Through Release 6.12. Cary, NC: SAS Institute Inc; 1997.
22. Rawlings JS, Smith FR. Transient tachypnea of the newborn: An analysis of neonatal and obstetric risk factors. Am J Dis Child. 1984;138:869-871.
23. Tudehope DI, Smyth MH. Is 'transient tachypnea of the newborn' always a benign disease? Report of 6 babies requiring mechanical ventilation. Aust Pediatr J. 1979;15:160-165.
24. Rubaltelli FF, Bonafe L, Tangucci M, Spagnolo A, Dani C. Epidemiology of neonatal acute respiratory disorders. Biol Neonate. 1998;74:7-15.
25. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Elective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis. 1983;148:810-816.
26. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91:112-114.
27. Easmon CS, Hastings MJG, Deeley J, et al. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. BJOG. 1983;90:633-635.
28. Yow MD, Mason EO, Leeds LJ, et al. Ampicillin prevents intrapartum transmission of group B streptococci. JAMA. 1979;241:1245-1247.
29. Murphy TV, Clements JF, Granoff DM. Excretion of Haemophilus influenzae type b polysaccharide antigen in urine of healthy nasopharyngeal carriers. Pediatr Res. 1989;26:491-495.
30. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep. 1996;45:1-24.